ESR1 and prostate cancer: The AR-positive human prostate cancer cell line LNCaP (derived from a metastatic prostate cancer lymph node lesion featuring androgen-sensitive growth and a mutation in the ligand binding domain of the AR) is the principal culture model used for investigating the complex interaction of ER and AR axis in prostate cancer.